Literature DB >> 19708996

Effects of uremic toxins on vascular and bone remodeling.

Fellype C Barreto1, Daniela V Barreto, Sophie Liabeuf, Tilman B Drüeke, Ziad A Massy.   

Abstract

Chronic kidney disease (CKD) is associated with both extensive vascular calcification and abnormal bone remodeling, namely renal osteodystrophy. Moreover, there is increasing evidence for a close relationship between bone and vessel function. Pathological vascular calcification has been recently recognized as an active, cell-mediated process with similarities to physiological skeletal mineralization. Accordingly, we described the concept of vascular remodeling, in analogy to bone remodeling. In this review, we discuss the role of uremic toxins in the cross-talk between bone and vessel, and emphasize their potential contribution to the development of both vascular and bone remodeling disorders in patients with CKD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19708996     DOI: 10.1111/j.1525-139X.2009.00595.x

Source DB:  PubMed          Journal:  Semin Dial        ISSN: 0894-0959            Impact factor:   3.455


  7 in total

Review 1.  Atherosclerosis in CKD: differences from the general population.

Authors:  Tilman B Drüeke; Ziad A Massy
Journal:  Nat Rev Nephrol       Date:  2010-10-26       Impact factor: 28.314

Review 2.  Leptin in chronic kidney disease: a link between hematopoiesis, bone metabolism, and nutrition.

Authors:  Jingjing Zhang; Ningning Wang
Journal:  Int Urol Nephrol       Date:  2013-12-14       Impact factor: 2.370

3.  CKD-mineral and bone disorder: core curriculum 2011.

Authors:  Ranjani N Moorthi; Sharon M Moe
Journal:  Am J Kidney Dis       Date:  2011-10-21       Impact factor: 8.860

4.  MicroRNAs 29b, 133b, and 211 Regulate Vascular Smooth Muscle Calcification Mediated by High Phosphorus.

Authors:  Sara Panizo; Manuel Naves-Díaz; Natalia Carrillo-López; Laura Martínez-Arias; José Luis Fernández-Martín; María Piedad Ruiz-Torres; Jorge B Cannata-Andía; Isabel Rodríguez
Journal:  J Am Soc Nephrol       Date:  2015-07-17       Impact factor: 10.121

5.  Metabolic alterations by indoxyl sulfate in skeletal muscle induce uremic sarcopenia in chronic kidney disease.

Authors:  Emiko Sato; Takefumi Mori; Eikan Mishima; Arisa Suzuki; Sanae Sugawara; Naho Kurasawa; Daisuke Saigusa; Daisuke Miura; Tomomi Morikawa-Ichinose; Ritsumi Saito; Ikuko Oba-Yabana; Yuji Oe; Kiyomi Kisu; Eri Naganuma; Kenji Koizumi; Takayuki Mokudai; Yoshimi Niwano; Tai Kudo; Chitose Suzuki; Nobuyuki Takahashi; Hiroshi Sato; Takaaki Abe; Toshimitsu Niwa; Sadayoshi Ito
Journal:  Sci Rep       Date:  2016-11-10       Impact factor: 4.379

6.  Impact of the Oral Adsorbent AST-120 on Organ-Specific Accumulation of Uremic Toxins: LC-MS/MS and MS Imaging Techniques.

Authors:  Emiko Sato; Daisuke Saigusa; Eikan Mishima; Taeko Uchida; Daisuke Miura; Tomomi Morikawa-Ichinose; Kiyomi Kisu; Akiyo Sekimoto; Ritsumi Saito; Yuji Oe; Yotaro Matsumoto; Yoshihisa Tomioka; Takefumi Mori; Nobuyuki Takahashi; Hiroshi Sato; Takaaki Abe; Toshimitsu Niwa; Sadayoshi Ito
Journal:  Toxins (Basel)       Date:  2017-12-28       Impact factor: 4.546

7.  The mRNA landscape profiling reveals potential biomarkers associated with acute kidney injury AKI after kidney transplantation.

Authors:  Hui Bi; Min Zhang; Jialin Wang; Gang Long
Journal:  PeerJ       Date:  2020-11-27       Impact factor: 2.984

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.